Drugs / AMG 994
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04727554 | Apr 2021 → Jun 2023 | cancer | Amgen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMG 994 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04727554 ↗ |
| Route | Intravenous | “AMG 994 will be administered by short term intravenous (IV) infusion once weekly” NCT04727554 ↗ |